Qiufen Xue - Concepedia

Author

Qiufen Xue

Amgen (United States)

Also Known As

Qiufen M. Xue, Qiufen Xue, Xue, Qiufen M.

Publications

200

Citations

H-Index

Concepts

All Affiliations

Amgen (United States)Bristol-Myers Squibb (United States)

About

Qiufen Xue is an author at Amgen (United States) specializing in drug discovery, molecular pharmacology, and medicinal chemistry.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	3	3	109
2	Natural Sciences	2	2	91
3	Biochemistry	2	2	91
4	Engineering	1	1	28
5	Biomolecular Engineering	1	1	18

Qiufen Xue

Publications

200

Citations

H-Index

Page 1

	Year	Citations
Design and Preparation of a Potent Series of Hydroxyethylamine Containing β-Secretase Inhibitors That Demonstrate Robust Reduction of Central β-Amyloid Matthew M. Weiss, Toni Williamson, Safura Babu‐Khan, Journal of Medicinal Chemistry	2012	63
Inhibitors of Human Immunodeficiency Virus Type 1 (HIV-1) Attachment. 12. Structure–Activity Relationships Associated with 4-Fluoro-6-azaindole Derivatives Leading to the Identification of 1-(4-Benzoylpiperazin-1-yl)-2-(4-fluoro-7-[1,2,3]triazol-1-yl-1<i>H</i>-pyrrolo[2,3-<i>c</i>]pyridin-3-yl)ethane-1,2-dione (BMS-585248) Alicia Regueiro‐Ren, Qiufen Xue, Jacob J. Swidorski, Journal of Medicinal Chemistry Vitro PotencyGood PotencyAzaindole CoreAntiviral DrugChemical Biology	2013	50
Design and Synthesis of Potent, Orally Efficacious Hydroxyethylamine Derived β-Site Amyloid Precursor Protein Cleaving Enzyme (BACE1) Inhibitors Thomas A. Dineen, Matthew M. Weiss, Toni Williamson, Journal of Medicinal Chemistry PharmacotherapyChemical BiologyPharmaceutical ChemistryPre-clinical PharmacologyTranslational Pharmacology	2012	41
An efficient one-pot synthesis of 3-glyoxylic acids of electron-deficient substituted azaindoles by ionic liquid imidazolium chloroaluminate-promoted Friedel–Crafts acylation Kap‐Sun Yeung, Zhilei Qiu, Michelle E. Farkas, Tetrahedron Letters Chemical Engineering3-Glyoxylic AcidsEngineeringElectron-deficient Substituted AzaindolesOrganic Chemistry	2008	28
Hydroxyethylamine-based inhibitors of BACE1: P1–P3 macrocyclization can improve potency, selectivity, and cell activity Lewis D. Pennington, Douglas A. Whittington, Michael D. Bartberger, Bioorganic & Medicinal Chemistry Letters Molecular PharmacologyMedicinal ChemistryMedicineDrug DiscoveryP1–p3 Macrocyclization	2013	18

Page 1